Cardiovascular diseases(CVDs) which include ischemic heart disease, stroke, heart failure, peripheral arterial disease, and several other cardiac and vascular illnesses, are the world's leading cause of mortality and significantly lower life expectancy. The research targeted at regulation of homocysteine metabolism has the potential to improve the quality of life and health span.